1. Home
  2. Labeler Index
  3. Regeneron Pharmaceuticals, Inc.
  4. 61755-020
  5. NDC Package Code: 61755-020-01 Praluent

NDC Package 61755-020-01 Praluent

Alirocumab Injection, Solution Subcutaneous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
61755-020-01
Package Description:
1 SYRINGE, GLASS in 1 CARTON / 1 mL in 1 SYRINGE, GLASS
Product Code:
61755-020
Proprietary Name:
Praluent
Non-Proprietary Name:
Alirocumab
Substance Name:
Alirocumab
Usage Information:
Alirocumab is used by people who have blockage in the heart blood vessels to reduce the risk of heart attack, stroke, and certain types of chest pain that require treatment in a hospital. It is also used by people who have an inherited condition that causes high levels of LDL. Treatment with alirocumab, a proper diet, and cholesterol-lowering drugs can help lower "bad" cholesterol (LDL) in the blood. Alirocumab belongs to a class of drugs known as monoclonal antibodies. It works by improving how well your body gets rid of LDL cholesterol. In addition to eating a proper diet (such as a low-cholesterol/low-fat diet), other lifestyle changes that may help this medication work better include exercising, losing weight if overweight, and stopping smoking. Consult your doctor for more details.
11-Digit NDC Billing Format:
61755002001
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
NDC to RxNorm Crosswalk:
  • RxCUI: 1659156 - alirocumab 150 MG in 1 ML Auto-Injector
  • RxCUI: 1659156 - 1 ML alirocumab 150 MG/ML Auto-Injector
  • RxCUI: 1659156 - alirocumab 150 MG per 1 ML Auto-Injector
  • RxCUI: 1659161 - Praluent 150 MG in 1 ML Auto-Injector
  • RxCUI: 1659161 - 1 ML alirocumab 150 MG/ML Auto-Injector [Praluent]
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Regeneron Pharmaceuticals, Inc.
    Dosage Form:
    Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
    Administration Route(s):
  • Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
    • Active Ingredient(s):
  • ALIROCUMAB 75 mg/mL
    • Pharmacologic Class(es):
  • Antibodies, Monoclonal - [CS]
  • PCSK9 Inhibitor - [EPC] (Established Pharmacologic Class)
  • PCSK9 Inhibitors - [MoA] (Mechanism of Action)
    • Sample Package:
    No
    FDA Application Number:
    BLA125559
    Marketing Category:
    BLA - A product marketed under an approved Biologic License Application.
    Start Marketing Date:
    12-01-2020
    Listing Expiration Date:
    12-31-2025
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    61755-020-022 SYRINGE, GLASS in 1 CARTON / 1 mL in 1 SYRINGE, GLASS
    61755-020-041 SYRINGE, GLASS in 1 CARTON / 1 mL in 1 SYRINGE, GLASS

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 61755-020-01?

    The NDC Packaged Code 61755-020-01 is assigned to a package of 1 syringe, glass in 1 carton / 1 ml in 1 syringe, glass of Praluent, a human prescription drug labeled by Regeneron Pharmaceuticals, Inc.. The product's dosage form is injection, solution and is administered via subcutaneous form.

    Is NDC 61755-020 included in the NDC Directory?

    Yes, Praluent with product code 61755-020 is active and included in the NDC Directory. The product was first marketed by Regeneron Pharmaceuticals, Inc. on December 01, 2020 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 61755-020-01?

    The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.

    What is the 11-digit format for NDC 61755-020-01?

    The 11-digit format is 61755002001. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-261755-020-015-4-261755-0020-01